GlaxoSmithKline

GlaxoSmithKline’s majority-owned HIV business to buy drugs from US rival Bristol-Myers Squibb

18 Dec 2015

GSK to sell its multiple sclerosis treatment drug to Novartis for $1 bn

21 Aug 2015

China to receive cut-price supplies of GSK’s new HIV drug Tivicay

02 Jul 2015

CCI Imposes Rs64 crore fine on GlaxoSmithKline, Sanofi

06 Jun 2015

CCI order comes on a complaint by Bio-Med, which alleged that GlaxoSmithKline and Sanofi collided in the tendering for meningitis vaccines in contravention of the provisions of the anti-trust Act, with passive help from the government

GSK, University of North Carolina in HIV cure venture

11 May 2015

Novartis-GSK business deal gets CCI nod

23 Dec 2014

GSK abandons sale of older drugs portfolio

05 Dec 2014

GlaxoSmithKline's $1.57-bn restructuring to hit US jobs

04 Dec 2014

GSK is struggling with declining sales, especially in the US, mainly due to a fall in its respiratory business, which accounted for 30 per cent of its global sales last year

Ebola virus gives birth to a new vaccine

28 Nov 2014

Over the long term, GlaxoSmithKline's new vaccine is intended to protect against all Ebola outbreaks, and the drug maker hopes to produce one million doses a month of the vaccine by the end of 2015